FUNDAMENTALS · Fundamentals · TH Healthcare

Rajthanee Hospital Public (RJH) Fundamentals 2026 — P/E 13.8x, Revenue Analysis | SniperIQ

Rajthanee Hospital Public (RJH) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿4.5B, trading at ฿15.20 on the SET. This SniperIQ fundamentals page covers Rajthanee Hospital Public's valuation (P/E 13.8x, P/B 2.0x), profitability (net margin 11.5%), revenue (฿2.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap฿4.5B
P/E (TTM)13.8x
Net Margin11.5%
Revenue (FY25)฿2.7B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Rajthanee Hospital Public's market cap?

Rajthanee Hospital Public (RJH) has a market capitalization of approximately ฿4.5B, trading at ฿15.20 on the SET. Market cap moves with the live share price.

What is Rajthanee Hospital Public's P/E ratio?

Rajthanee Hospital Public's trailing twelve-month P/E ratio is 13.8x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Rajthanee Hospital Public?

Rajthanee Hospital Public runs a net profit margin of 11.5%, a gross margin of 24.8%, and an operating margin of 13.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Rajthanee Hospital Public generate?

Rajthanee Hospital Public reported revenue of ฿2.7B for fiscal year 2025, with net income of ฿295M and earnings per share (EPS) of 1.01. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Rajthanee Hospital Public pay a dividend?

Rajthanee Hospital Public offers a trailing dividend yield of about 3.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Rajthanee Hospital Public financially healthy?

Rajthanee Hospital Public carries a debt-to-equity ratio of 0.64x and a current ratio of 0.73x, with a market beta of 0.06. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Rajthanee Hospital Public a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Rajthanee Hospital Public (RJH) the key facts are: market cap ฿4.5B, P/E 13.8x, revenue ฿2.7B, 52-week range 11.1-15.2. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Rajthanee Hospital Public's full fundamentals live

Get Rajthanee Hospital Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Shenzhen Weiguang Biological Products (002880) fundamentals · Jianmin Pharmaceutical Group (600976) fundamentals · Truking Technology (300358) fundamentals · Teyi Pharmaceutical Group (002728) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons